Redx Pharma

Developer of small molecule medicines for fibrotic disease and oncology

placeLiverpool, England, United Kingdom calendar_todayFounded 2010 groups89 employees language redxpharma.com

Registered entities

Innovation

158 patent families (21 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,716 times.

YearFilings
201542
201636
201724
201810
201910
20205
20217
202211
202318
202419
202516
20265

Social engagement

Social engagement: 12.6K social following, 8 posts in the last 12 months — around the industry typical range.

Investor mix

9 investors on record; 3 have since exited.

Investor typeCountShare
Venture capital111%
Private equity333%
Other / undisclosed556%

Recent activity

19 Nov 2025
Event
What's Next for Fibrosis? Understanding the Future Directions of the Antifibrotic Field
18 Nov 2025
Event
9th Annual Antifibrotic Drug Development Summit
16 Nov 2025
Event
9th Annual Antifibrotic Drug Development Summit
Coming soon